The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

References

• Von Mutius E. The rising trends in asthma and allergic disease. Clin Exp Allergy 1998;28:45–9
   PubMed Web of Science ®Google Scholar
• Nathan RA, Meltzer EO, Selner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:S808–S814
   Google Scholar
• Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106:S201–S205
   Google Scholar
• Simons FER. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1999;104:534–40
   PubMed Web of Science ®Google Scholar
• Vignola AM, Chanez P, Bousquet J. The relationship between asthma and allergic rhinitis: exploring the basis for a common pathophysiology. Clin Exp Allergy Rev 2003;3:63–8
   Google Scholar
• Casale TB, Lazarus SC. Immunobiology of asthma and rhinitis: pathogenic factors and therapeutic options. Am J Respir Crit Care Med 1999;160:1778–87
   PubMedGoogle Scholar
• Braunstahl GJ, Fokkens W. Nasal involvement in allergic asthma. Allergy 2003;58:1235–43
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001:107:469–76
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000;161:2051–7
   PubMed Web of Science ®Google Scholar
• Dahlen S-E. Cysteinyl leukotrienes as common mediators of asthma and allergic disease. Clin Exp Allergy Rev 2003;3:69–73
   Google Scholar
• Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator, and permeability changes. Am Rev Respir Dis 1991;144:51–8
   PubMed Web of Science ®Google Scholar
• Lam S, Chan H, LeRiche JC, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711–7
   PubMed Web of Science ®Google Scholar
• Wenzel SE. The role of leukotrienes in asthma. Prostaglandins Leukot Essent Fatty Acids 2003;69:145–55
   PubMed Web of Science ®Google Scholar
• Howarth PH. Leukotrienes in asthma. Am J Respir Crit Care Med 2000; 161:S133–S136
   Google Scholar
• Borish L. Allergic rhinitis: systemic inflammation and implications for management. J Allergy Clin Immunol 2003;112:1021–31
   PubMed Web of Science ®Google Scholar
• Pawankar R. Exploring the role of leukotriene receptor antagonists in the management of allergic rhinitis and comorbid asthma. Clin Exp Allergy Rev 2003;3:74–80
   Google Scholar
• Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109:57–62
   Google Scholar
• Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med 1998;158:1213–20
   PubMed Web of Science ®Google Scholar
• Reiss TF, Knorr B, Malmstrom K, Noonan G, Lu S. Clinical efficacy of montelukast in adults and children. Clinical and Experimental Allergy Rev 2001;1:264–73
   Google Scholar
• Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000;105:917–22
   PubMed Web of Science ®Google Scholar
• Nayak A, Philip G, Lu S, Malice M-P, Reiss TF, Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002;88:592–600
   Google Scholar
• Philip G, Malmstrom K, Hampel Jr FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002;32:1020–8
   PubMed Web of Science ®Google Scholar
• van Adelsberg J, LaForce CF, Weinstein SF, et al. Randomized controlled trial evaluating clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003a;90:214–22
   PubMed Web of Science ®Google Scholar
• van Adelsberg J, Philip G, Pedinoff AJ, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003b;58:1268–76
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77–83
   PubMed Web of Science ®Google Scholar
• Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997;99:S742–S748
   Google Scholar
• Bousquet J. Allergic rhinitis and its impact on asthma (ARIA). Clin Exp Allergy Rev 2003;3:43–5
   Google Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N, ARIA Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147–S334
   PubMedGoogle Scholar
• Canonica GW. Evaluation and management of patients with asthma and allergic rhinitis: exploring the potential role for leukotriene receptor antagonists. Clin Exp Allergy Rev 2003;3:61–2
   Google Scholar
• Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003;111:1171–83
   PubMed Web of Science ®Google Scholar
• Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000;162:1391–6
   Google Scholar
• Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. Br Med J 2003;327:891–7
   PubMed Web of Science ®Google Scholar
• Bousquet J, Sazonov Kocevar V, Zhang Q, Yin, DD, Polos P. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the IMPACT trial. Accepted for presentation at the 2004 Annual Conference of the European Academy of Allergy, Asthma and Immunology (EAACI), Amsterdam, The Netherlands, June 2004. Poster Session Asthma I, General Aspects (02); Poster No. 141
   Google Scholar
• Price DB, Zhang Q, Sazonov Kocevar V, Yin D, Thomas M. Effect of concomitant allergic rhinitis on asthma-related hospitalizations, general practitioner visits, and drug costs among adults in the United Kingdom. Clin Exp Allergy [in press]
   Google Scholar
• Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003;21:116–22
   PubMed Web of Science ®Google Scholar
• Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2001;31(4):616–24
   PubMed Web of Science ®Google Scholar
• Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130: 307–13
   Google Scholar
• Ciprandi G, Tosca MA, Milanese M, Schenone G, Ricca V. Anti-histamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism. Allerg Immunol 2004;36:67–70
   Google Scholar
• Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Ann Intern Med 1999;130:487–95
   PubMed Web of Science ®Google Scholar
• Price DB, Hernandez D, Magyar P, et al. [COMPACT International Study Group]. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211–6
   Google Scholar
• Price DB, Swern AS, Tozzi CA, Philip G, Polos P. Additional benefit of montelukast for asthma in patients with both asthma and allergic rhinitis: analysis from the COMPACT trial. Allergy Clin Immunol Int 2003;(Supp 1):29
   Google Scholar
• Perry TT, Corren J, Philip G, et al. Protective effect of montelukast on lower and upper respiratory responses to acute cat allergen exposure. Ann Allergy Asthma Immunol [in press]
   Google Scholar